These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11987918)

  • 1. Molecular measurement of minimal residual disease in Philadelphia-positive acute lymphoblastic leukaemia.
    Radich JP
    Best Pract Res Clin Haematol; 2002 Mar; 15(1):91-103. PubMed ID: 11987918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Tabayashi T; Yamada K; Takeuchi M
    Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu JF
    Haematologica; 2000 Jul; 85(7):704-10. PubMed ID: 10897122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
    Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A
    Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.
    Pane F; Cimino G; Izzo B; Camera A; Vitale A; Quintarelli C; Picardi M; Specchia G; Mancini M; Cuneo A; Mecucci C; Martinelli G; Saglio G; Rotoli B; Mandelli F; Salvatore F; Foà R;
    Leukemia; 2005 Apr; 19(4):628-35. PubMed ID: 15744351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction analysis of BCR-ABL sequences in adult Philadelphia chromosome-negative acute lymphoblastic leukemia patients.
    Janssen JW; Fonatsch C; Ludwig WD; Rieder H; Maurer J; Bartram CR
    Leukemia; 1992 May; 6(5):463-4. PubMed ID: 1593911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment.
    Scheuring UJ; Pfeifer H; Wassmann B; Brück P; Gehrke B; Petershofen EK; Gschaidmeier H; Hoelzer D; Ottmann OG
    Leukemia; 2003 Sep; 17(9):1700-6. PubMed ID: 12970767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of minimal residual disease in Ph+/bcr-abl+ acute lymphoblast leukemia by cytogenetic analysis, nested-PCR and flow cytometry].
    Xue F; Dong ZR; Zhang B; Gao LX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Aug; 11(4):372-5. PubMed ID: 12962565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
    Radich J; Gehly G; Lee A; Avery R; Bryant E; Edmands S; Gooley T; Kessler P; Kirk J; Ladne P; Thomas ED; Appelbaum FR
    Blood; 1997 Apr; 89(7):2602-9. PubMed ID: 9116308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The monitoring of BCR-ABL mRNA by reverse transcription PCR in patients undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukemia with a positive Philadelphia chromosome].
    Román J; Castillejo JA; Jiménez A; Maldonado J; Torres A
    Med Clin (Barc); 1999 Dec; 113(20):779-82. PubMed ID: 10680143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of minimal residual disease in patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia using a real-time RT-PCR assay.
    Yokota H; Tsuno NH; Tanaka Y; Fukui T; Kitamura K; Hirai H; Osumi K; Itou N; Satoh H; Okabe M; Nakahara K
    Leukemia; 2002 Jun; 16(6):1167-75. PubMed ID: 12040449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.
    Yoon JH; Min GJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Lee S
    Cancer; 2019 Mar; 125(6):873-883. PubMed ID: 30521062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
    Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
    Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia.
    Coccaro N; Anelli L; Zagaria A; Casieri P; Tota G; Orsini P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Carluccio P; Brunetti C; Specchia G; Albano F
    J Mol Diagn; 2018 Jul; 20(4):474-482. PubMed ID: 29625246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives.
    Faderl S; Garcia-Manero G; Thomas DA; Kantarjian HM
    Rev Clin Exp Hematol; 2002 Jun; 6(2):142-60; discussion 200-2. PubMed ID: 12196213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia.
    van Rhee F; Kasprzyk A; Jamil A; Dickinson H; Lin F; Cross NC; Galvin MC; Goldman JM; Secker-Walker LM
    Br J Haematol; 1995 May; 90(1):225-8. PubMed ID: 7786793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia.
    Šálek C; Folber F; Froňková E; Procházka B; Marinov I; Cetkovský P; Mayer J; Doubek M;
    Eur J Haematol; 2016 Mar; 96(3):276-84. PubMed ID: 25997106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
    Stirewalt DL; Guthrie KA; Beppu L; Bryant EM; Doney K; Gooley T; Appelbaum FR; Radich JP
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):206-12. PubMed ID: 12652472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
    Hidaka M; Inokuchi K; Uoshima N; Takahashi N; Yoshida N; Ota S; Nakamae H; Iwasaki H; Watanabe K; Kosaka Y; Komatsu N; Meguro K; Najima Y; Eto T; Kondo T; Kimura S; Yoshida C; Ishikawa Y; Sawa M; Hata T; Horibe K; Iida H; Shimomura T; Dobashi N; Sugiura I; Makiyama J; Miyagawa N; Sato A; Ito R; Matsumura I; Kanakura Y; Naoe T
    Jpn J Clin Oncol; 2024 Feb; 54(2):153-159. PubMed ID: 37986553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow.
    van Rhee F; Marks DI; Lin F; Szydlo RM; Hochhaus A; Treleaven J; Delord C; Cross NC; Goldman JM
    Leukemia; 1995 Feb; 9(2):329-35. PubMed ID: 7869772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.